AI assistant
Sending…
Surgery Partners, Inc. — Director's Dealing 2022
Mar 2, 2022
31430_dirs_2022-03-02_d1cac73b-eae1-4435-834b-0b3bfb064c05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Surgery Partners, Inc. (SGRY)
CIK: 0001638833
Period of Report: 2022-02-10
Reporting Person: Doherty David T (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-25 | Common Stock | S | 2221 | $50.48 | Disposed | 59435 | Direct |
| 2022-02-10 | Common Stock | A | 4460 | $42.04 | Acquired | 63895 | Direct |
Footnotes
F1: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 24, 2022.
F2: Shares issued based on 2021 performance under performance stock unit awards granted to the Reporting Person on March 10, 2021. Shares will vest in two equal annual installments on each of the first two anniversaries of February 10, 2022.
More from Surgery Partners, Inc.
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 5
Director's Dealing
2026
Jan 15